News
Being a mom is a full-time job, with plenty of moving parts to keep track of. For mothers on the lookout for products and ...
PARIS — Results from the REMAIN long-term follow-up study on MCO-010, an optogenetic therapy for retinitis pigmentosa, showed durable efficacy over 3 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results